Tweets by IDWeek 2023

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

386 Views

044. COVID-19: Complications, Coinfections and Clinical Outcomes: Thursday, 12:15 - 1:30 p.m.

Poster Session: COVID-19: Complications, Coinfections and Clinical Outcomes

(419) Viral SARS-CoV-2 rebound rates in linked commercial pharmacy-based SARS-CoV-2 RT-qPCR testing and healthcare claims

Thursday, October 12, 2023

12:15 PM – 1:30 PM US ET

Location: Hall B + C

Presenting Author(s)

LM

Lisa M. McEwen, PhD

Helix
San Mateo, California, United States
SK

Scott P. Kelly, PhD

Senior Director, Vaccines and Hospital Epidemiology Lead
Pfizer
New York, New York, United States
MI

Magnus Isaksson, PhD

Helix
San Mateo, California, United States
SM

Sarah Murphy, n/a

Formerly Helix
Boston, Massachusetts, United States
SW

Simon White, n/a

Principle Bioinformatics Engineer
Helix
San Mateo, California, United States
JM

JT McCrone, PhD

Helix
San Mateo, California, United States
GL

Geraint Levan, n/a

Helix
San Mateo, California, United States
SS

Sharad Santhanam, n/a

Helix
San Mateo, California, United States
Mary Lynn Baniecki, PhD

Head of Infectious Disease for Translational Medicine
Pfizer Inc
Cambridge, Massachusetts, United States
CB

Candace Bramson, MD

Pfizer Inc
Ann Arbor, Michigan, United States
HR

Heather Rubino, PhD, MS

Head
Pfizer
tallahassee, Florida, United States
VH

Victoria Hendrick, BSc

Pfizer
Sandwich, England, United Kingdom
HS

Holly Soares, PhD

Head Precision Medicine
Pfizer
Groton, Connecticut, United States
Jennifer Hammond, PhD

Head of Antiviral Development
Pfizer Inc
Collegeville, PA, United States